These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 24872214)
1. Clinically amyopathic dermatomyositis: analysis of a monocentric cohort. Neri R; Barsotti S; Iacopetti V; Tripoli A; dʼAscanio A; Tavoni AG; Mosca M; Bombardieri S J Clin Neuromuscul Dis; 2014 Jun; 15(4):157-60. PubMed ID: 24872214 [TBL] [Abstract][Full Text] [Related]
2. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. Gerami P; Schope JM; McDonald L; Walling HW; Sontheimer RD J Am Acad Dermatol; 2006 Apr; 54(4):597-613. PubMed ID: 16546580 [TBL] [Abstract][Full Text] [Related]
3. Clinically amyopathic dermatomyositis: clinical features, response to medications and malignancy-associated risk factors in a specific tertiary-care-centre cohort. Galimberti F; Li Y; Fernandez AP Br J Dermatol; 2016 Jan; 174(1):158-64. PubMed ID: 26490490 [TBL] [Abstract][Full Text] [Related]
4. Clinical, histologic and prognostic features of clinically amyopathic dermatomyositis. Fornaro M; Girolamo F; Giannini M; Coladonato L; Capuano A; Capodiferro M; D'Abbicco D; Ruggieri M; Mastrapasqua M; Iannone F Clin Exp Rheumatol; 2024 Feb; 42(2):288-294. PubMed ID: 38488091 [TBL] [Abstract][Full Text] [Related]
5. Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis. Moghadam-Kia S; Oddis CV; Sato S; Kuwana M; Aggarwal R J Rheumatol; 2017 Mar; 44(3):319-325. PubMed ID: 28089977 [TBL] [Abstract][Full Text] [Related]
6. Clinical Characteristics and Management of Patients With Clinical Amyopathic Dermatomyositis: A Retrospective Study of 64 Patients at a Tertiary Dermatology Department. Tang K; Zhang H; Jin H Front Med (Lausanne); 2021; 8():783416. PubMed ID: 34926528 [No Abstract] [Full Text] [Related]
8. [Clinical features and risk factors associated with interstitial lung disease in patients with classic dermatomyositis or clinical amyopathic dermatomyositis]. Lin H; Liang Y; Wang Y; Cen XM; Yin G; Xie QB Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):805-9. PubMed ID: 24325117 [TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Sato S; Hirakata M; Kuwana M; Suwa A; Inada S; Mimori T; Nishikawa T; Oddis CV; Ikeda Y Arthritis Rheum; 2005 May; 52(5):1571-6. PubMed ID: 15880816 [TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and symptom progression of dermatomyositis subtypes: A retrospective analysis of a prospective database. Pandya R; Kleitsch J; Lim D; Werth VP J Am Acad Dermatol; 2024 Jul; 91(1):31-36. PubMed ID: 38342246 [TBL] [Abstract][Full Text] [Related]
11. Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis. Azuma K; Yamada H; Ohkubo M; Yamasaki Y; Yamasaki M; Mizushima M; Ozaki S Mod Rheumatol; 2011 Apr; 21(2):178-83. PubMed ID: 20922453 [TBL] [Abstract][Full Text] [Related]
12. Nomogram to predict dermatomyositis prognosis: a population-based study of 457 cases. Li Y; Li Y; Wang Y; Shi L; Lin F; Zhang Z; Zhang J; Xu F; Sun X Clin Exp Rheumatol; 2022 Feb; 40(2):247-253. PubMed ID: 34528507 [TBL] [Abstract][Full Text] [Related]
13. Dysregulation of the type I interferon system in adult-onset clinically amyopathic dermatomyositis has a potential contribution to the development of interstitial lung disease. Sun WC; Sun YC; Lin H; Yan B; Shi GX Br J Dermatol; 2012 Dec; 167(6):1236-44. PubMed ID: 23013528 [TBL] [Abstract][Full Text] [Related]
14. Measurement of cytokines and chemokines and association with clinical severity of dermatomyositis and clinically amyopathic dermatomyositis. Chen M; Quan C; Diao L; Xue F; Xue K; Wang B; Li X; Zhu X; Zheng J; Cao H Br J Dermatol; 2018 Dec; 179(6):1334-1341. PubMed ID: 30101523 [TBL] [Abstract][Full Text] [Related]
16. Treatment challenges in clinically amyopathic dermatomyositis: A case series and review of new therapeutic options for skin involvement. Rodríguez-Tejero A; López-Espadafor B; Montero-Vílchez T; Sánchez-Díaz M; Arias-Santiago S; Molina-Leyva A Dermatol Ther; 2021 May; 34(3):e14942. PubMed ID: 33719170 [TBL] [Abstract][Full Text] [Related]
17. Number, characteristics, and classification of patients with dermatomyositis seen by dermatology and rheumatology departments at a large tertiary medical center. Klein RQ; Teal V; Taylor L; Troxel AB; Werth VP J Am Acad Dermatol; 2007 Dec; 57(6):937-43. PubMed ID: 17923170 [TBL] [Abstract][Full Text] [Related]
18. Gottron Papules and Gottron Sign with Ulceration: A Distinctive Cutaneous Feature in a Subset of Patients with Classic Dermatomyositis and Clinically Amyopathic Dermatomyositis. Cao H; Xia Q; Pan M; Zhao X; Li X; Shi R; Zhou M; Ding X; Kuwana M; Zheng J J Rheumatol; 2016 Sep; 43(9):1735-42. PubMed ID: 27307530 [TBL] [Abstract][Full Text] [Related]
19. Clinically Amyopathic Dermatomyositis Complicated by Pleural Effusion Case Report, Literature Review, and Proposed Mechanism. Wu Y; Chhaya S; Hurowitz B; Ardiles T; Carlson R Bull Hosp Jt Dis (2013); 2015 Jul; 73(3):217-20. PubMed ID: 26535603 [TBL] [Abstract][Full Text] [Related]